Rep. Doggett Statement on Lower Drug Costs Now Act
September 19, 2019
September 19, 2019
WASHINGTON, Sept. 19 -- Rep. Lloyd Doggett, D-Texas, chair of the House Ways and Means subcommittee on Health, issued the following statement regarding the Lower Drug Costs Now Act (H.R. 3):
"This legislation is stronger because of progressive involvement, but more is required, including addressing negotiation scope, sky-high launch prices, and price-spike protection for all patients.
"My goal remains delivering the most relief possible for the most patients a . . .
"This legislation is stronger because of progressive involvement, but more is required, including addressing negotiation scope, sky-high launch prices, and price-spike protection for all patients.
"My goal remains delivering the most relief possible for the most patients a . . .